Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Intrexon Corp (XON) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010904
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, and autoimmune disorders. Intrexon’s UltraVector platform produces and optimizes custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. The company offers RheoSwitch therapeutic system for inducible expression of single and multi-gene systems through an activator ligand. It has partnership with the channel of network collaborators and joint ventures to commercialize its technologies. Intrexon is headquartered in Germantown, Maryland, the US.

Intrexon Corp (XON) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Intrexon Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Intrexon Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Intrexon Secures US$1.1 Million In Venture Financing 10
Immunologix Raises US$0.25 Million In Venture Financing 11
Intrexon Raises US$100 Million In Series E Financing 12
Partnerships 13
OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 13
Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 15
Equity Offering 16
Intrexon to Raise USD100 Million in Private Placement of Preferred Shares 16
Acquisition 17
Intrexon to Acquire GenVec 17
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 19
Intrexon Corp – Key Competitors 21
Intrexon Corp – Key Employees 22
Intrexon Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Mar 10, 2017: Intrexon Creates Precigen and Accelerates Strategic Review of Structural Options Related to Health Assets 25
Financial Announcements 26
Nov 09, 2017: Intrexon Announces Third Quarter 2017 Financial Results 26
Aug 09, 2017: Intrexon Announces Second Quarter and First Half 2017 Financial Results 29
May 10, 2017: Intrexon Announces First Quarter 2017 Financial Results 31
Mar 01, 2017: Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results 33
Nov 09, 2016: Intrexon Announces Third Quarter 2016 Financial Results 36
Corporate Communications 39
Nov 27, 2017: Intrexon Announces Key Management Appointments 39
Jun 29, 2017: Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen 41
May 18, 2017: Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec 42
Apr 27, 2017: Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Intrexon Corp, Medical Equipment, Key Facts, 2016 2
Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Intrexon Corp, Deals By Market, 2011 to YTD 2017 8
Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Intrexon Secures US$1.1 Million In Venture Financing 10
Immunologix Raises US$0.25 Million In Venture Financing 11
Intrexon Raises US$100 Million In Series E Financing 12
OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 13
Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 15
Intrexon to Raise USD100 Million in Private Placement of Preferred Shares 16
Intrexon to Acquire GenVec 17
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 19
Intrexon Corp, Key Competitors 21
Intrexon Corp, Key Employees 22
Intrexon Corp, Subsidiaries 23
Intrexon Corp, Joint Venture 24

★海外企業調査レポート[Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Tinplate Company of India Limited:企業の戦略・SWOT・財務情報
    The Tinplate Company of India Limited - Strategy, SWOT and Corporate Finance Report Summary The Tinplate Company of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Korea East-West Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Navigator Holdings Ltd (NVGS):企業の財務・戦略的SWOT分析
    Summary Navigator Holdings Ltd (Navigator) operates as an oil and gas company that offers seaborne transportation of liquefied gases. The company transports ammonia, ethane, ethylene, ambient LPG, petrochemicals and LPG products. It provides fleet management, ship management, gas transportation and …
  • Widex AS:企業の戦略的SWOT分析
    Widex AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nutreco N.V.:企業の戦略・SWOT・財務情報
    Nutreco N.V. - Strategy, SWOT and Corporate Finance Report Summary Nutreco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • NuGEN Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA …
  • Siliconware Precision Industries Co., Ltd.:企業の戦略的SWOT分析
    Siliconware Precision Industries Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • BASF SE (BAS):製薬・医療:M&Aディール及び事業提携情報
    Summary BASF SE (BASF) is a chemical company, which carries out the research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additive …
  • Townsquare Media, Inc.:企業のM&A・事業提携・投資動向
    Townsquare Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Townsquare Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Antilles Oil and Gas NL (AVD):石油・ガス:M&Aディール及び事業提携情報
    Summary Antilles Oil and Gas NL (Antilles) is an upstream oil and gas company that carries out the acquisition and exploration of petroleum and gas properties. The company acquires underperforming assets and re-evaluates to identify untapped recoverable reserves. The company’s operates an exploratio …
  • Aratana Therapeutics Inc (PETX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • Acciona Energia SA:企業の戦略的SWOT分析
    Acciona Energia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Orly International, Inc.:企業の戦略・SWOT・財務分析
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Specialist Computer Centres Plc:企業の戦略・SWOT・財務情報
    Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report Summary Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • High Energy Batteries (India) Ltd:企業の戦略・SWOT・財務分析
    High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務情報
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Petroleum Geo-Services ASA (PGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleum Geo-Services ASA (PGS) is a marine geophysical company. The company provides a wide range of products including seismic and electromagnetic services, data acquisition, processing, reservoir analysis/interpretation and MultiClient library data. Its MultiClient data library is among …
  • Memphasys Ltd (MEM):製品パイプライン分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • Boston Children’s Hospital:企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆